Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
369 News Items found
Announcement
Nathanael Gray, Joshua Mendell, and Christopher Vakoc
Three Scientists Are Named Winners of the Paul Marks Prize for Cancer Research

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising investigators.
In the Lab
a colorful dendritic cell
Newly Discovered Immune Cell Subtypes Could Shake Up Immunotherapy

Dendritic cells, the guards of the immune system, have a previously unrecognized division of labor.
In the Clinic
MSK patient receiving chemotherapy
6 Breakthroughs That Are Changing Chemotherapy for People with Breast Cancer

Discover some of the latest innovations in chemotherapy for breast cancer.
In the Lab
Physician-scientist Omar Abdel-Wahab in his lab.
Targeting Errors in How Proteins Are Made Is a Promising Approach for Cancer Treatment

MSK studies look at the role of RNA splicing factors in acute myeloid leukemia and melanoma.
In the Lab
Blue cells on a black background
Scientists Create the First Human-Tumor-Derived Model for Studying Rectal Cancer

Scientists at Memorial Sloan Kettering have created a model of rectal cancer using human-tumor-derived organoids.
Finding
Red blood cells
Research Points to a Potential New Approach for Treating Anemia

A class of drugs originally developed to treat certain neurological disorders appears to boost the production of red blood cells.
Q&A
Pediatric oncologist Julia Glade Bender
Meet Julia Glade Bender, Who’s Focused on Developing Better Treatments for Kids with Cancer

Pediatric oncologist Julia Glade Bender talks about the challenges of treating rare childhood cancers and how personalized medicine is leading to better therapies for tumors that are especially hard to treat.
In the Lab
illustration of the p53 protein binding to a DNA helix
New Findings Clarify How the “Guardian of the Genome” Works

Surprise! It has to do with metabolism.
Finding
A micrograph of a cell nucleus
How an Altered Gatekeeping Protein Can Cause Cancer

An MSK study explains how the drug selinexor, which was recently approved to treat multiple myeloma and is being tested in many other tumor types, stops cancer.
Finding
What Causes Leukemia after Breast Cancer? Research Shows That a Mutation May Be Present All Along

A study from MSK takes a deeper look at some of the causes of secondary leukemia.